Institutional Sign In

Go

Amgen Czech Republic

Created with Highcharts 6.0.4Sales and Profits (CZK mil)SalesNet Profit200520062007200820092010201120122013201420152016201702505007500204060

Amgen CR's Cash & Cash Equivalents rose 5.20% yoy to CZK 0.283 mil in 2017

By Helgi Library - April 2, 2020

Amgen Czech Republic's total assets reached CZK 261 mil at the end of 2017, down 11% compared to the previous year. ...

Amgen CR's Cash & Cash Equivalents rose 5.20% yoy to CZK 0.283 mil in 2017

By Helgi Library - April 2, 2020

Amgen Czech Republic's total assets reached CZK 261 mil at the end of 2017, down 11% compared to the previous year. ...

Profit Statement 2015 2016 2017
Sales CZK mil 604 626 417
Gross Profit CZK mil 159 152 162
EBITDA CZK mil 46.3 38.8 49.0
EBIT CZK mil 44.3 38.1 48.5
Financing Cost CZK mil 0.330 0.142 0.335
Pre-Tax Profit CZK mil 44.0 38.0 48.2
Net Profit CZK mil 35.8 31.5 37.8
Dividends CZK mil 0 60.0 ...
Balance Sheet 2015 2016 2017
Total Assets CZK mil 276 293 261
Non-Current Assets CZK mil 1.43 1.12 0.726
Current Assets CZK mil 274 291 260
Working Capital CZK mil 67.4 282 248
Shareholders' Equity CZK mil 183 214 192
Liabilities CZK mil 93.3 78.5 68.6
Total Debt CZK mil 71.8 0 0
Net Debt CZK mil 70.7 -0.269 -0.283
Ratios 2015 2016 2017
ROE % 18.4 15.9 18.6
ROCE % 36.6 17.9 14.2
Gross Margin % 26.3 24.2 38.8
EBITDA Margin % 7.66 6.20 11.8
EBIT Margin % 7.34 6.09 11.6
Net Margin % 5.93 5.03 9.06
Net Debt/EBITDA 1.53 -0.007 -0.006
Net Debt/Equity % 38.7 -0.125 -0.147
Cost of Financing % 0.592 0.396 ...
Cash Flow 2015 2016 2017
Total Cash From Operations CZK mil 130 -13.1 118
Total Cash From Investing CZK mil -69.9 12.4 -58.4
Total Cash From Financing CZK mil -60.0 0 -60.0
Net Change In Cash CZK mil -0.159 -0.749 0.014
Cash Conversion Cycle days 37.6 163 211
Cash Earnings CZK mil 37.8 32.2 38.3
Free Cash Flow CZK mil 59.8 -0.749 60.0

Get all company financials in excel:

Download Sample   $19.99